328.27
price down icon7.04%   -27.21
after-market 시간 외 거래: 328.20 -0.07 -0.02%
loading
전일 마감가:
$355.48
열려 있는:
$351.79
하루 거래량:
1.30M
Relative Volume:
1.56
시가총액:
$23.09B
수익:
$3.22B
순이익/손실:
$542.70M
주가수익비율:
43.88
EPS:
7.4805
순현금흐름:
$458.00M
1주 성능:
-7.75%
1개월 성능:
-2.92%
6개월 성능:
+39.64%
1년 성능:
+18.41%
1일 변동 폭
Value
$327.97
$351.79
1주일 범위
Value
$329.20
$386.00
52주 변동 폭
Value
$223.83
$386.00

West Pharmaceutical Services Inc Stock (WST) Company Profile

Name
명칭
West Pharmaceutical Services Inc
Name
전화
(610) 594-2900
Name
주소
530 HERMAN O. WEST DRIVE, EXTON, PA
Name
직원
10,800
Name
트위터
@WestPharma
Name
다음 수익 날짜
2026-07-23
Name
최신 SEC 제출 서류
Name
WST's Discussions on Twitter

Compare WST vs ISRG, BDX, ALC, MDLN, RMD

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
WST icon
WST
West Pharmaceutical Services Inc
327.99 25.03B 3.22B 542.70M 458.00M 7.4805
ISRG icon
ISRG
Intuitive Surgical Inc
337.47 118.96B 11.03B 3.16B 2.83B 8.7254
BDX icon
BDX
Becton Dickinson Co
156.35 42.15B 21.37B 1.41B 3.07B 3.9437
ALC icon
ALC
Alcon Inc
67.89 32.78B 10.63B 819.00M 1.59B 1.6577
MDLN icon
MDLN
Medline Inc
38.75 31.82B 29.14B 1.07B 1.05B 1.1956
RMD icon
RMD
Resmed Inc
195.30 27.83B 5.54B 1.52B 1.74B 10.37

West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-12-02 개시 Morgan Stanley Equal-Weight
2025-09-15 개시 Rothschild & Co Redburn Buy
2025-06-24 개시 Barclays Equal Weight
2025-03-18 개시 Evercore ISI Outperform
2025-02-14 업그레이드 Deutsche Bank Hold → Buy
2025-01-08 개시 Citigroup Buy
2024-12-13 개시 Wolfe Research Peer Perform
2024-12-12 업그레이드 UBS Neutral → Buy
2024-02-07 업그레이드 Jefferies Hold → Buy
2023-06-16 업그레이드 BofA Securities Neutral → Buy
2023-04-11 업그레이드 Stephens Equal-Weight → Overweight
2022-12-14 개시 Deutsche Bank Hold
2022-11-30 개시 UBS Neutral
2022-10-28 다운그레이드 BofA Securities Buy → Neutral
2020-11-10 개시 KeyBanc Capital Markets Overweight
2020-10-14 개시 Stephens Equal-Weight
2020-07-21 업그레이드 BofA Securities Neutral → Buy
2020-04-24 업그레이드 BofA/Merrill Underperform → Neutral
2019-12-12 다운그레이드 BofA/Merrill Neutral → Underperform
2019-07-26 업그레이드 BofA/Merrill Underperform → Neutral
2019-05-01 다운그레이드 Jefferies Buy → Hold
2019-04-23 개시 William Blair Outperform
2018-04-25 다운그레이드 BofA/Merrill Neutral → Underperform
2018-01-24 개시 Goldman Neutral
2017-10-17 다운그레이드 BofA/Merrill Buy → Neutral
2017-10-03 개시 Stephens Equal-Weight
2017-09-15 업그레이드 Jefferies Hold → Buy
2016-10-28 업그레이드 Wells Fargo Market Perform → Outperform
2016-09-21 다운그레이드 Wells Fargo Outperform → Market Perform
2016-03-22 개시 Wells Fargo Outperform
2010-05-14 재확인 UBS Neutral
2010-02-23 개시 Jefferies & Co Buy
2008-12-19 개시 UBS Neutral
모두보기

West Pharmaceutical Services Inc 주식(WST)의 최신 뉴스

pulisher
11:36 AM

West Pharmaceutical Services Q2 2026 Earnings: Revenue, Net Income, and Financial Highlights - Minichart

11:36 AM
pulisher
11:30 AM

Hims & Hers Health, Repligen, West Pharmaceutical Services, and 10x Genomics Stocks Trade Down, What You Need To Know - TradingView

11:30 AM
pulisher
11:09 AM

Here's Why You Should Add Cencora Stock to Your Portfolio Now - TradingView

11:09 AM
pulisher
08:29 AM

West Pharmaceutical beats 2Q26 estimates, raises full-year sales and EPS guidance. - Pluang

08:29 AM
pulisher
08:08 AM

West Pharmaceutical Delivers Another BeatBut The Real Story Is The Mix Shift (NYSE:WST) - Seeking Alpha

08:08 AM
pulisher
06:11 AM

West Pharmaceutical Services, I (WST) Stock Forecasts - Yahoo Finance

06:11 AM
pulisher
02:39 AM

West Pharmaceutical's Long-Term Growth Intact - Morningstar

02:39 AM
pulisher
01:36 AM

West Pharmaceutical stock trades steady as recent earnings highlight margin resilience - Ad-hoc-news.de

01:36 AM
pulisher
01:35 AM

WST Q2 Deep Dive: Biologics and High-Value Components Drive Upgraded Outlook - TradingView

01:35 AM
pulisher
01:00 AM

West Pharmaceutical Services, Inc. 2026 Q2ResultsEarnings Call Presentation (NYSE:WST) 2026-07-24 - Seeking Alpha

01:00 AM
pulisher
Jul 23, 2026

West Pharmaceutical Services Q2 Earnings Call Highlights - TradingView

Jul 23, 2026
pulisher
Jul 23, 2026

West Pharmaceutical Services, Inc. (WPS) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks

Jul 23, 2026
pulisher
Jul 23, 2026

West Pharmaceutical Services, Inc. (WPS) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks

Jul 23, 2026
pulisher
Jul 23, 2026

West Pharmaceutical (WST) Receives Strong Outlook Amidst Quarterly Performance - GuruFocus

Jul 23, 2026
pulisher
Jul 23, 2026

West Pharmaceutical Services, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance

Jul 23, 2026
pulisher
Jul 23, 2026

West Pharmaceutical Services Inc 2Q 2026: Revenue $872.3M, EPS $2.15— 10-Q Summary - TradingView

Jul 23, 2026
pulisher
Jul 23, 2026

[10-Q] WEST PHARMACEUTICAL SERVICES INC Quarterly Earnings Report - Stock Titan

Jul 23, 2026
pulisher
Jul 23, 2026

West Pharma says sterile packaging upgrades fuel demand for high-value plastics - Plastics News

Jul 23, 2026
pulisher
Jul 23, 2026

West Pharmaceutical Services Inc (WST) Q2 2026 Earnings Call Highlights: Strong Organic Growth ... - Yahoo Finance

Jul 23, 2026
pulisher
Jul 23, 2026

West Pharmaceutical Services Inc (WST) Q2 2026 Earnings Call Hig - GuruFocus

Jul 23, 2026
pulisher
Jul 23, 2026

WST Stock Jumps on Q2 Earnings & Sales Beat, EPS View Up on HVP Growth - TradingView

Jul 23, 2026
pulisher
Jul 23, 2026

West Pharmaceutical Services (WST) Reports Strong Q2 2026 Earnin - GuruFocus

Jul 23, 2026
pulisher
Jul 23, 2026

West Pharma raises profit forecast on strong demand for injectable drug components - 1470 & 100.3 WMBD

Jul 23, 2026
pulisher
Jul 23, 2026

Tranche Update on West Pharmaceutical Services, Inc.'s Equity Buyback Plan announced on February 17, 2026. - marketscreener.com

Jul 23, 2026
pulisher
Jul 23, 2026

West Pharmaceutical CEO Highlights GLP-1 And Biologics Momentum - Benzinga

Jul 23, 2026
pulisher
Jul 23, 2026

West Pharmaceutical Services, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Jul 23, 2026
pulisher
Jul 23, 2026

Why is West Pharmaceutical Services stock surging today? - Investing.com

Jul 23, 2026
pulisher
Jul 23, 2026

Earnings call transcript: West Pharmaceutical beats Q2 2026 estimates, lifts outlook - Investing.com

Jul 23, 2026
pulisher
Jul 23, 2026

West Pharmaceutical (WST) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance

Jul 23, 2026
pulisher
Jul 23, 2026

Full Transcript: West Pharmaceutical Servs Q2 2026 Earnings Call - Benzinga

Jul 23, 2026
pulisher
Jul 23, 2026

West Pharmaceutical Services Releases Q2 2026 Financial Results - AlphaStreet

Jul 23, 2026
pulisher
Jul 23, 2026

Is West Pharmaceutical Services Inc (WST) Undervalued After Q2 E - GuruFocus

Jul 23, 2026
pulisher
Jul 23, 2026

West Pharmaceutical Services, I (WST) Q2 FY2026 earnings call transcript - Yahoo Finance

Jul 23, 2026
pulisher
Jul 23, 2026

West Pharmaceutical Services (NYSE:WST) Beats Expectations in Strong Q2 CY2026, Stock Soars - Yahoo Finance

Jul 23, 2026
pulisher
Jul 23, 2026

Form 8-K WEST PHARMACEUTICAL SERV For: Jul 23 - StreetInsider

Jul 23, 2026
pulisher
Jul 23, 2026

West Pharmaceutical Services (WST) Q2 Earnings and Revenues Top Estimates - Yahoo Finance

Jul 23, 2026
pulisher
Jul 23, 2026

West Pharma stock rises 6% on strong earnings beat and raised guidance - Investing.com Canada

Jul 23, 2026
pulisher
Jul 23, 2026

West Pharmaceutical raises FY2026 sales and EPS guidance - scanx.trade

Jul 23, 2026
pulisher
Jul 23, 2026

West Pharmaceutical raises annual profit forecast on strong demand for injectable drug components - marketscreener.com

Jul 23, 2026
pulisher
Jul 23, 2026

(WST) West Pharmaceutical Services, Inc. Expects Q3 Revenue Range $820.0M$835.0M - marketscreener.com

Jul 23, 2026
pulisher
Jul 23, 2026

West Pharmaceutical Services earnings beat by $0.29, revenue topped estimates - Investing.com Canada

Jul 23, 2026
pulisher
Jul 23, 2026

(WST) West Pharmaceutical Services Expects Full Year 2026 Adjusted EPS Range $8.85$9.05, vs. FactSet Est of $8.62 - marketscreener.com

Jul 23, 2026
pulisher
Jul 23, 2026

(WST) West Pharmaceutical Services, Inc. Expects Q3 Adjusted EPS Range $2.14$2.24 - marketscreener.com

Jul 23, 2026
pulisher
Jul 23, 2026

Earnings Flash (WST) West Pharmaceutical Services, Inc. Reports Q2 Revenue $872.3M, vs. FactSet Est of $840.0M - marketscreener.com

Jul 23, 2026
pulisher
Jul 23, 2026

(WST) West Pharmaceutical Services Expects Full Year 2026 Net Sales Range $3.35B$3.38B vs. FactSet Est of $3.33B - marketscreener.com

Jul 23, 2026
pulisher
Jul 23, 2026

Earnings Flash (WST) West Pharmaceutical Services, Inc. Posts Q2 Adjusted EPS $2.37 per Share, vs. FactSet Est of $2.08 - marketscreener.com

Jul 23, 2026
pulisher
Jul 23, 2026

West Pharmaceutical Services Inc (WST) Earnings: FY Adjusted EPS Forecast Raised Following Strong Q2 Results - Smartkarma

Jul 23, 2026
pulisher
Jul 23, 2026

West Pharmaceutical: Q2 Earnings Snapshot - Yahoo Finance

Jul 23, 2026
pulisher
Jul 23, 2026

Earnings Flash (WST) West Pharmaceutical Services, Inc. Posts Q2 Adjusted EPS $2.37 per Share, Vs. FactSet Est of $2.08 - Moomoo

Jul 23, 2026
pulisher
Jul 23, 2026

West Reports Second-Quarter 2026 Results - TradingView

Jul 23, 2026
pulisher
Jul 22, 2026

West Pharmaceutical stock holds steady on 2026 earnings context - Ad-hoc-news.de

Jul 22, 2026

West Pharmaceutical Services Inc (WST) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

West Pharmaceutical Services Inc 주식 (WST) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Favorite Annette F
Sr. VP & Chief HR Officer
Apr 27 '26
Option Exercise
83.47
2,817
235,135
19,645
Favorite Annette F
Sr. VP & Chief HR Officer
Apr 27 '26
Sale
305.20
2,817
859,753
16,828
Winters Chad
VP, Chief Accounting Officer
Apr 27 '26
Option Exercise
173.22
896
155,205
2,419
Winters Chad
VP, Chief Accounting Officer
Apr 27 '26
Sale
300.67
896
269,399
1,523
RMD RMD
$195.30
price up icon 1.94%
COO COO
$70.31
price up icon 0.12%
$77.99
price up icon 1.02%
$38.94
price up icon 3.40%
ALC ALC
$67.89
price up icon 1.15%
자본화:     |  볼륨(24시간):